Intra Hospital Mortality Risk Factors in Patients Admitted to Cardiac Intensive Care Units in 2017 in France

NCT03835169 | Completed

• 1 other identifier: RECHMPL18_0429
• Study Type: observational
• Target: 200,000
• Locations: 1 country
• Sites: 1

Brief Summary

Retrospective, observational cohort study. Objectives: To identify intra hospital mortality risk factors in patients admitted admitted to cardiac intensive care units (CICU). The clinical main endpoint will be the observed percentage of deaths that occured during the year 2017 in french CICU. To identify the length of stay key determiners of patients admitted in french CICU. The study will use data from one of the french nationwide healthcare systems database (SNDS) : the national hospital discharge database (PMSI) to be precise.

Conditions

Heart Disease; Acute Coronary Syndrome; Acute Cardiac Failure; Heart Rhythm Disorders; Valve Pathologies

Keywords

Cardiac intensive care unit; Organization; Prognostic score

Outcome Measures

Primary Outcomes (1)

• Mortality rate

  Observed percentage of deaths that occured during the year 2017 in french CICU

  1 day

Secondary Outcomes (1)

• Length of stay at a CICU

  1 year

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients admitted (at least one time) in a french CICU in 2017

You may qualify if:

• Being admitted at least one time in a french CICU in 2017
• Being covered by the mandatory french national health insurance plan in 2017 without discontinuity

You may not qualify if:

• Being older than 18 years of age

Sponsors & Collaborators

• University Hospital, Montpellier: lead

Study Sites (1)

Uhmontpellier

Montpellier, 34295, France

Location

MeSH Terms

Conditions

Heart Diseases; Acute Coronary Syndrome; Arrhythmias, Cardiac

Condition Hierarchy (Ancestors)

Cardiovascular Diseases; Myocardial Ischemia; Vascular Diseases; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• François Roubille, MD, PhD

  University Hospital, Montpellier

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 24, 2019
• First Posted: February 8, 2019
• Study Start: January 24, 2019
• Primary Completion: December 1, 2020
• Study Completion: December 30, 2020
• Last Updated: August 11, 2022

Record last verified: 2022-08

Locations

FR (1)